These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 20007426

  • 1. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
    Ramil E, Sánchez AJ, González-Pérez P, Rodríguez-Antigüedad A, Gómez-Lozano N, Ortiz P, Arroyo R, De las Heras V, Vilches C, García-Merino A.
    Mult Scler; 2010 Feb; 16(2):139-46. PubMed ID: 20007426
    [Abstract] [Full Text] [Related]

  • 2. The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis.
    Rossi S, Buttari F, Studer V, Motta C, Gravina P, Castelli M, Mantovani V, De Chiara V, Musella A, Fiore S, Masini S, Bernardi G, Maccarrone M, Bernardini S, Centonze D.
    Mult Scler; 2011 Mar; 17(3):281-8. PubMed ID: 21148019
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis.
    Schrijver HM, van As J, Crusius JB, Dijkstra CD, Uitdehaag BM.
    Mediators Inflamm; 2003 Apr; 12(2):89-94. PubMed ID: 12775358
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis.
    Giovannoni G.
    Mult Scler; 2011 Mar; 17(3):259-61. PubMed ID: 21362756
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor necrosis factor-alpha-308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients.
    Ristić S, Lovrecić L, Starcević-Cizmarević N, Brajenović-Milić B, Sega Jazbec S, Sepcić J, Kapović M, Peterlin B.
    Eur Neurol; 2007 Mar; 57(4):203-7. PubMed ID: 17268200
    [Abstract] [Full Text] [Related]

  • 11. A polymorphism in the repetitive (TGGA)n sequence 5' to the human myelin basic protein gene in Italian multiple sclerosis patients.
    Guerini FR, Losciale L, Mediati M, Speciale L, Mancuso R, Saresella M, Calvo MG, Caputo D, Ferrante P.
    J Neurovirol; 2000 May; 6 Suppl 2():S28-32. PubMed ID: 10871781
    [Abstract] [Full Text] [Related]

  • 12. No association of CNR1 gene variations with susceptibility to schizophrenia.
    Seifert J, Ossege S, Emrich HM, Schneider U, Stuhrmann M.
    Neurosci Lett; 2007 Oct 09; 426(1):29-33. PubMed ID: 17881126
    [Abstract] [Full Text] [Related]

  • 13. Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis.
    Benešová Y, Vašků A, Stourač P, Hladíková M, Fiala A, Bednařík J.
    J Neuroimmunol; 2013 Feb 15; 255(1-2):92-6. PubMed ID: 23186557
    [Abstract] [Full Text] [Related]

  • 14. Is tumor necrosis factor-376A promoter polymorphism associated with susceptibility to multiple sclerosis?
    Kauffman MA, Morón DG, Sandoval G, Sica RE, Garcea O, Villa AM.
    Medicina (B Aires); 2007 Feb 15; 67(5):436-8. PubMed ID: 18051225
    [Abstract] [Full Text] [Related]

  • 15. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
    Sola P, Mandrioli J, Simone AM, Ferraro D, Bedin R, Annecca R, Venneri MG, Nichelli PF, Merelli E.
    Mult Scler; 2011 Mar 15; 17(3):303-11. PubMed ID: 21078694
    [Abstract] [Full Text] [Related]

  • 16. Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients.
    Otaegui D, Zuriarrain O, Castillo-Triviño T, Aransay A, Ruíz-Martinez J, Olaskoaga J, Marti-Masso J, Lopez de Munain A.
    Mult Scler; 2009 Jan 15; 15(1):124-8. PubMed ID: 18755822
    [Abstract] [Full Text] [Related]

  • 17. Glypican 5 is an interferon-beta response gene: a replication study.
    Cénit MD, Blanco-Kelly F, de las Heras V, Bartolomé M, de la Concha EG, Urcelay E, Arroyo R, Martínez A.
    Mult Scler; 2009 Aug 15; 15(8):913-7. PubMed ID: 19556317
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression.
    Almeras L, Meresse B, Seze J, De Lefranc D, Dubucquoi S, Fajardy I, Vermersch P, Prin L.
    Eur Cytokine Netw; 2002 Aug 15; 13(2):200-6. PubMed ID: 12101075
    [Abstract] [Full Text] [Related]

  • 19. PAI and TPA gene polymorphisms in multiple sclerosis.
    Lovrecic L, Ristić S, Starcević-Cizmarević N, Brajenović-Milić B, Jazbec SS, Sepcić J, Kapović M, Peterlin B.
    Mult Scler; 2008 Mar 15; 14(2):243-7. PubMed ID: 17986506
    [Abstract] [Full Text] [Related]

  • 20. The variant methylenetetrahydrofolate reductase c.1298A>C (p.E429A) is associated with multiple sclerosis in a German case-control study.
    Klotz L, Farkas M, Bain N, Keskitalo S, Semmler A, Ineichen B, Jelcic J, Klockgether T, Kölsch H, Weller M, Linnebank M.
    Neurosci Lett; 2010 Jan 14; 468(3):183-5. PubMed ID: 19854238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.